Joshua G Cohen

5PUBLICATIONS
134CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologySurgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 31, 2023
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).

Rebecca C Arend, Bradley J Monk, Ronnie Shapira-Frommer

|Oct 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.

Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield

|Aug 18, 2022
The increasing incidence of stage IV cervical cancer in the USA: what factors are related?

Alex Andrea Francoeur, Cheng-I Liao, Michelle Ann Caesar

Pageof 1